Drugs / pulmonary surfactant
last change Jun 1990 re-read 3 minutes ago

pulmonary surfactant

Developed for
respiratory distress syndrome in premature infants
Investigated by
National Heart, Lung, and Blood Institute (NHLBI)

Trials 1

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00000570 Jan 1986 → Jun 1990 respiratory distress syndrome in premature infants National Heart, Lung, and Blood Institute (NHLBI) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as pulmonary surfactant ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000570 ↗
Action Restore “Therefore, studies of replacement therapy for surfactant deficiency have used complete natural surfactants or derivatives of natural surfactant” NCT00000570 ↗
Route Other “prophylactic surfactant treatment given intratracheally” NCT00000570 ↗